GlassScriptPhysician profile
Allison Passarella
NPI 1053965384
$718.71
in general payments reported to CMS, 2019-2025
14 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $268 · 2022: $264 · 2023: $61.57 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $186.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $209.97 | 2021-2023 | Ozempic, Rybelsus |
| Lilly USA, LLC | $140.67 | 2023-2025 | Zepbound, Emgality, Jardiance |
| Abbvie INC. | $61.96 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $58.06 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $57.89 | 2021-2022 | |
| Glaxosmithkline, LLC. | $34.59 | 2022-2023 | Arexvy |
| Amgen INC. | $29.16 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $27.81 | 2021-2023 | Pneumovax 23, Vaxneuvance, Gardasil 9 |
| Almatica Pharma LLC | $23.68 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $16.69 | 2022 | |
| Arbor Pharmaceuticals, INC. | $16.52 | 2021 | |
| Sanofi Pasteur INC. | $15.29 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $13.52 | 2021 | |
| Corium, LLC | $12.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Passarella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.